Here and for the first time, we have demonstrated that the neddylation pathway is activated in most renal cancer cells, as evidenced by comparative analysis of APP-BP1 and Ubc12 levels in renal tumor tissues and in healthy bone tissues. This evidence concerns the gene UBE2M and renal carcinoma.